Cargando…
ODP591 Obesity and Weight Loss Apps in COVID-19 Era: Do They Help Both the Doctor and the Patient?
BACKGROUND: Obesity and high BMI are risk factors for COVID-19 affecting>190M adults in the US. Televisits increased from 15K to 25M in October 2020. With 218B downloads, apps are popular. During COVID19, obesity and weight loss apps could be useful for telehealth for doctors and patients with ob...
Autores principales: | Lawrence, Rebecca, Dunaif, Andrea, Agarwal, Parul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624685/ http://dx.doi.org/10.1210/jendso/bvac150.027 |
Ejemplares similares
-
MON-591 Effect of Liraglutide Treatment on Proglucagon-Derived Peptides
por: Kim, Sun, et al.
Publicado: (2020) -
SUN-591 PAPP-A Inhibition - a Novel Anti-Obesity Therapeutic Approach
por: Ramakrishna, Akhila, et al.
Publicado: (2020) -
Weight Loss Mobile Apps: Do They Address COVID-19 and Diabetes
por: Wu, Gloria, et al.
Publicado: (2021) -
SAT-591 Lack of Adipose-Specific Hexose-6-Phosphate Dehydrogenase Improves Fat Metabolic Phenotype and Increases Insulin Sensitivity in Mice
por: Wang, Jian, et al.
Publicado: (2020) -
ODP008 Nonalcoholic Fatty Liver Disease (NAFLD) Impacts Weight Loss after Bariatric Surgery
por: Abu-Rumaileh, Mohammed, et al.
Publicado: (2022)